Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. (2019)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/acel.13027
PubMed Identifier: 31493351
Publication URI: http://europepmc.org/abstract/MED/31493351
Type: Journal Article/Review
Volume: 18
Parent Publication: Aging cell
Issue: 6
ISSN: 1474-9718